Concepedia

Toshihiko Shiraiwa

TS

Statistics

Publications

38

Citations

2.1K

H-Index

24

Active since

2005

Affiliations

The University of Osaka(Current)

Juntendo University

Koto Hospital

Osaka City General Hospital

Osaka Prefectural Medical Center

Toshihiko Shiraiwa is an author at The University of Osaka specializing in medicine, diabetes mellitus, and diabetology.

Publications per year

2005–2023

38

Publications

38

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

, , +15

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto et al. · The Lancet Diabetes & Endocrinology · 2020 · 203 citations

, , +15

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Tomoya Mita, Naoto Katakami, Hidenori Yoshii et al. · Diabetes Care · 2015 · 163 citations

, , +17

Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation

Takeshi Miyatsuka, Hideaki Kaneto, Toshihiko Shiraiwa et al. · Genes & Development · 2006 · 156 citations · Full text

, , +14

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)

Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa et al. · Diabetes Care · 2016 · 141 citations

, , +17

1–5 of 38